New blood test could detect ovarian cancer early, improve treatment

High-grade serous ovarian carcinoma (HGSOC) is the most common type of ovarian cancer. It is also the most lethal form, in part because clinicians do not have effective ways to screen women for it during the cancer’s early stages, when it’s easiest to treat.

Roche partner touts early allogeneic CAR-T data at #ASH23, but durability remains key question

SAN DIEGO — Poseida Therapeutics revealed the most complete data so far for the allogeneic CAR-T program that it licensed to Roche last year. But

December 11, 2023

New method to assess the status of immune responses to specific antigens in detail

A new method to assess the status of immune responses to specific antigens in detail by analysis using the B cell receptor (BCR) repertoire has

August 18, 2023

Major Heart Risks Similar With Two IBD Drugs in Older Adults

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major cardiovascular adverse events (MACE) for those taking

February 11, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.